Home

Perceptive Advisors reported a 3.2% stake in Contineum Therapeutics CTNM · 699,486 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
3.2%
Last report
7.5% · filed 25/05/15
Shares held
699,486 sh
Class
Class A Common Stock, par value $0.001 per share
Event date
25/06/30
Filed
25/08/14

3.2% stake · below 5%

Stake
3.2%
Last report
7.5%
Since last report
−4.3pp

Contineum Therapeutics trades, last 26 weeks

What else happened in Contineum Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Perceptive Advisors's other 5% stake reports

  • Perceptive Advisors

    5% stakeKardigan

    8.8% stake

    Filed 10/01

  • Perceptive Advisors

    5% stakeNurix Therapeutics

    5.3% stake

    Filed 09/23

  • Perceptive Advisors

    5% stakeImmatics

    7.6% stake

    Filed 08/27

  • Perceptive Advisors

    5% stakeLeonaBio

    19.99% stake

    Filed 08/25

  • Perceptive Advisors

    5% stakeSolid Biosciences

    11.2% stake

    Filed 08/14